Across Cancer Types
We are taking a diligent and broad approach in some of the most challenging, but potentially most impactful, areas of cancer research. We have developed a robust pipeline of homegrown and licensed/partnered clinical assets with a diverse range of mode of actions, including cancer cell-directed and immuno-oncology investigational therapies. It’s the smart combination of these approaches that may offer the greatest benefit for people living with cancer.
We have developed a robust pipeline of clinical assets including immuno-oncology investigational therapies, find out more about them here.
Latest Articles on Across Cancer Types
Across Cancer Types
Cancer’s Big 4, our focus on KRAS
Drugging the undruggable
Across Cancer Types
How scientific congresses drive patient benefit
What is happening behind the doors of congress centers? How do patients benefit from the participation of pharmaceutical representatives? Let’s shed some light.
Links
MyStudyWindow
Answer a few questions to find a potential study for you.
Discover InOncology.com
A knowledge hub providing information and education in oncology for healthcare professionals